ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

insulin degludec

Also written as “insulin degludec/insulin aspart”, “insulin degludec/liraglutide” and “Insulin degludec”.

Its studies are mostly in Diabetes Mellitus, Type 2 · Diabetes Mellitus, Type 1 · Diabetes Mellitus, led by 5 companies.

Drug pageInsulin degludec: every studyMany companies study it; this page follows only the 105 they lead. All 128 studies, academic ones too, with its approvals and label.
Furthest: phase 4, since Sep 21, 2018105 company-led studies, 4 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Novo Nordisk1000 open or runningphase 4since Sep 21, 2018Jan 30, 2008none ahead
Tonghua Dongbao Pharmaceuticalits history only22 open or runningphase 3since Aug 14, 2024Jun 2, 2024none ahead
Gan & Lee Pharmaceuticalsits history only11 open or runningphase 1since Aug 18, 2025Aug 18, 2025none ahead
Sino Biopharmaceuticalits history only11 open or runningphase 3since Jul 5, 2021Jul 5, 2021none ahead
Sunshine Lake Pharmaits history only10 open or runningphase 3since Mar 6, 2023Mar 6, 2023none ahead

Also a collaborator on its studies: Profil Institut für Stoffwechselforschung.

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

Before these, 43 studies since Jan 6, 2011.

  1. Apr 8, 2015Phase 3 study in Diabetes MellitusNCT02420262 · 506 enrolled · United States, Argentina, Czechia and more
  2. Jul 15, 2015Phase 3 study in Diabetes MellitusNCT02501161 · 1,012 enrolled · United States, Argentina, Brazil and more
  3. Aug 28, 2015Phase 1 study in Diabetes MellitusNCT02536859 · 60 enrolled · Germany
  4. Nov 16, 2015Phase 3 study in Diabetes MellitusNCT02607306 · 819 enrolled · Japan
  5. Jan 5, 2016Phase 3 study in Diabetes MellitusNCT02648217 · 263 enrolled · Algeria, India, Lebanon and more
  6. May 3, 20162 phase 3 studies in Diabetes MellitusNCT02762578, NCT02773368
  7. Jul 22, 2016Phase 1 study in HealthyNCT02844790 · 24 enrolled · China
  8. Sep 15, 20162 phase 3 studies in Diabetes MellitusNCT02906917, NCT02911948
  9. Mar 10, 2017Phase 3 study in Diabetes MellitusNCT03078478 · 1,609 enrolled · United States, Canada, Denmark and more
  10. May 24, 20172 phase 3 studies in Diabetes MellitusNCT03175120, NCT03172494
  11. Sep 19, 2017Phase 1 study in Diabetes MellitusNCT03292185 · 24 enrolled · China
  12. Nov 16, 2017Phase 3 study in Diabetes MellitusNCT03377699 · 225 enrolled · Argentina, Australia, Austria and more
  13. Sep 21, 2018Phase 4 study in Diabetes Mellitus, Type 2NCT03687827 · 498 enrolled · United States, Canada, Poland and more
  14. Mar 10, 2021Phase 3 study in Diabetes Mellitus, Type 2NCT04795531 · 588 enrolled · United States, Argentina, Austria and more

TargetBeta

INSR →read by rule
“Insulin receptor agonist”ChEMBL 37, by rule

Other programs on INSR

ProgramCompanyFurthest phaseStudies
Insulin GlargineruleSanofiphase 4190
Insulin AspartruleNovo Nordiskphase 4146
InsulinrulePfizerphase 450
insulin glulisineruleSanofiphase 443
insulin icodecruleNovo Nordiskphase 430
linsitinibruleAstellas Pharmaphase 313
LY3938577Eli Lillyphase 23

Studies

The newest 60 of 100 Novo Nordisk leads. Each opens its study page. Every study on its drug page →

StudyPhaseStatusPrimary completionSize
NCT04795531Diabetes Mellitus, Type 2 · United States, Argentina, Austria and more3CompletedJun 23, 2022588
NCT03687827Diabetes Mellitus, Type 2 · United States, Canada, Poland and more4CompletedDec 20, 2019498
NCT03377699Diabetes Mellitus · Argentina, Australia, Austria and more3CompletedDec 17, 2020225
NCT03292185Diabetes Mellitus · China1CompletedJan 2, 201824
NCT03175120Diabetes Mellitus · China, Hong Kong3CompletedMar 5, 2019453
NCT03172494Diabetes Mellitus · China3CompletedJun 14, 2019720
NCT03078478Diabetes Mellitus · United States, Canada, Denmark and more3CompletedFeb 13, 20191,609
NCT02911948Diabetes Mellitus · Japan3CompletedNov 17, 2017210
NCT02906917Diabetes Mellitus · United States, Algeria, Czechia and more3CompletedAug 31, 2017532
NCT02844790Healthy · China1CompletedSep 26, 201624
NCT02773368Diabetes Mellitus · United States, Argentina, Canada and more3CompletedSep 26, 2017420
NCT02762578Diabetes Mellitus · China3CompletedMay 19, 2017543
NCT02648217Diabetes Mellitus · Algeria, India, Lebanon and more3CompletedSep 4, 2016263
NCT02607306Diabetes Mellitus · Japan3CompletedDec 15, 2017819
NCT02536859Diabetes Mellitus · Germany1CompletedApr 14, 201660
NCT02501161Diabetes Mellitus · United States, Argentina, Brazil and more3CompletedOct 3, 20181,012
NCT02420262Diabetes Mellitus · United States, Argentina, Czechia and more3CompletedOct 5, 2016506
NCT02298192Diabetes Mellitus · United States, Austria, Bulgaria and more3CompletedDec 23, 2015420
NCT02100475Diabetes Mellitus · United States, Argentina, Australia and more3CompletedApr 201531
NCT02034513Diabetes Mellitus · United States, Poland, Puerto Rico3CompletedJan 11, 2016501
NCT02030600Diabetes Mellitus · United States, Puerto Rico3CompletedDec 4, 2015721
NCT01959529Diabetes Mellitus · United States, Algeria, Argentina and more3CompletedOct 16, 20167,637
NCT01952145Diabetes Mellitus · United States, Argentina, Australia and more3CompletedNov 4, 2014557
NCT01916174Diabetes Mellitus · Germany1CompletedNov 201350
NCT01880736Diabetes Mellitus · Japan3CompletedApr 2014458
NCT01868581Diabetes Mellitus · Germany1CompletedAug 200858
NCT01868568Diabetes Mellitus · Germany1CompletedAug 200855
NCT01868555Diabetes Mellitus · Japan1CompletedFeb 200832
NCT01868529Diabetes Mellitus · Germany1CompletedJun 200863
NCT01865331Diabetes Mellitus · Germany1CompletedMar 200732
NCT01865318Diabetes Mellitus · Germany1CompletedJan 200736
NCT01865305Diabetes Mellitus · Germany1CompletedFeb 200759
NCT01865292Diabetes Mellitus · Germany1CompletedNov 200640
NCT01849289Diabetes Mellitus · United States, Brazil, Canada and more3CompletedMay 15, 2014833
NCT01835431Diabetes Mellitus · United States, Belgium, Brazil and more3CompletedNov 7, 2014362
NCT01814137Diabetes Mellitus · United States, Algeria, Germany and more3CompletedMar 201440
NCT01773798Diabetes Mellitus · Austria1CompletedAug 201333
NCT01713530Diabetes Mellitus · United States, Algeria, Austria and more3CompletedJan 9, 2014274
NCT01704417Diabetes Mellitus · Germany1CompletedMar 201340
NCT01680341Diabetes Mellitus · United States, Algeria, Germany and more3CompletedAug 22, 2013272
NCT01676116Diabetes Mellitus · United States, Australia, France and more3CompletedMar 11, 2014438
NCT01664247Diabetes Mellitus · United States, Canada, France and more3CompletedDec 31, 2013346
NCT01618162Diabetes Mellitus · United States, Bulgaria, Canada and more3CompletedOct 23, 2013435
NCT01623375Diabetes Mellitus · Germany1CompletedAug 201218
NCT01590836Diabetes Mellitus · Germany1CompletedJun 201222
NCT01570751Diabetes Mellitus · United States, Puerto Rico3CompletedJan 2014145
NCT01569841Diabetes Mellitus · United States3CompletedNov 201224
NCT01513590Diabetes Mellitus · Algeria, Bulgaria, Croatia and more3CompletedNov 19, 2012394
NCT01513473Diabetes Mellitus · United States, Bulgaria, Finland and more3CompletedJul 30, 2013350
NCT01467414Diabetes Mellitus · Germany1TerminatedDec 20111
NCT01455142Diabetes Mellitus · Austria1CompletedJan 201232
NCT01437592Diabetes Mellitus · China1CompletedNov 22, 201124
NCT01392573Diabetes Mellitus · United States, Bulgaria, Denmark and more3CompletedOct 1, 2012413
NCT01388361Diabetes Mellitus · United States, Austria, Belgium and more3CompletedJul 2012413
NCT01365507Diabetes Mellitus · United States, Korea, Republic of, Malaysia and more3CompletedApr 2012276
NCT01364428Diabetes Mellitus · United States3CompletedJan 2012373
NCT01336023Diabetes Mellitus · United States, Australia, Canada and more3CompletedMay 24, 20121,663
NCT01326026Diabetes Mellitus · United States, Finland, Germany and more3CompletedDec 2011222
NCT01319240Diabetes Mellitus · Germany1CompletedMay 201124
NCT01272193Diabetes Mellitus · Japan3CompletedSep 2011296

How it is read

Names in the registry

  • “insulin degludec”, 73 entries
  • “insulin degludec/insulin aspart”, 35 entries
  • “insulin degludec/liraglutide”, 17 entries
  • “Insulin degludec”, 4 entries
  • “Insulin degludec/liraglutide”, 3 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.